Cambridge Crossing Signs Philips Technologies as First Tenant to 45-Acre Development Site

BOSTON—Philips, an international health technology leader, recently signed as the first tenant of the initial phase of Cambridge Crossing. The firm will occupy 250 North Street (Parcel J/K) of the larger 45-acre mixed-use development site owned by DivcoWest spanning Cambridge, Somerville, and Boston.

Philips has executed a long-term lease for 243,000 square feet and will relocate its innovation and commercial healthcare technology teams from Andover, MA as well as its existing Cambridge-based North American Research Center to the new building. Cambridge Crossing’s close proximity to Kendall Square within one of the highest concentrations of talent and intellectual capital in the world will likely attract more health and technology firms like Philips.

Formerly a rail yard, Cambridge Crossing will be a new mixed-use neighborhood with research facilities, residential units, and retail amenities in a compact, walkable, and transit- and bicycle-friendly plan that will become an integral part of the existing East Cambridge neighborhood. Specifically, two MBTA transit lines, including the new Lechmere Station of the Green Line Extension, will directly serve the site.

Upon the completion of construction, Cambridge Crossing will contain approximately 2.1 million square feet of state-of-the-art science and technology space, approximately 2,400 new residential units in addition to approximately 2,500 existing units, and approximately 100,000 square feet of retail thoughtfully curated to deliver a unique and local neighborhood experience. The project will also include approximately 11 acres of activated public open spaces in addition to a central common area. The unique plan of Cambridge Crossing will likely further the transformation of the area into a breeding ground for technological development.